Table 1.

Relationship between clinical parameters and GATA6 methylation among the 60 patients with gastric cancer.

	GATA6 Methylation % 1 (n)	p
Age		0.163
≥60	50.36 ± 5.48% (10)
<60	42.82 ± 2.12% (50)
Sex		0.873
Male	43.87 ± 2.18% (43)
Female	44.59 ± 4.55% (17)
Stage		0.497
I–II	42.60 ± 2.99% (28)
III–IV	45.36 ± 2.72% (32)
Grade 2		0.497
Low	42.60 ± 2.99% (28)
High	45.36 ± 2.72% (32)

¹ Mean methylation % ± standard deviation (SD); ² Pathological grade, low: G1–2; high: G3–4.